[1] D. Schuppan, N. H. Afdhal, Liver cirrhosis, Lancet 371 (2008) 838–851.
[2] D. Moradpour, H. E. Blum, Pathogenesis of hepatocellular carcinoma, European Journal Of Gastroenterology & Hepatology 17 (2005) 477–483.
[3] A. Arzumanyan, H. M. G. P. V. Reis, M. A. Feitelson, Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma, Nature Reviews Cancer 13 (2013) 123–135.
[4] Y. Shokoohinia, M. Rashidi, L. Hosseinzadeh, Z. Jelodarian, Quercetin–3-O-beta-D-glucopyranoside, a dietary flavonoid, protects PC12 cells from H2O2-induced cytotoxicity through inhibition of reactive oxygen species, Food Chemistry 167 (2015) 162–167.
[5] H. Sonoki, T. Sato, S. Endo, T. Matsunaga, M. Yamaguchi, Y. Yamazaki, J. Sugatani, A. Ikari, Quercetin Decreases Claudin–2 Expression Mediated by Up-Regulation of microRNA miR–16 in Lung Adenocarcinoma A549 Cells, Nutrients 7 (2015) 4578–4592.
[6] M. Pinelo, L. Manzocco, M. J. Nunez, M. C. Nicoli, Solvent effect on quercetin antioxidant capacity, Food Chemistry 88 (2004) 201–207.
[7] T. Hatahet, M. Morille, A. Shamseddin, A. Aubert-Pouessel, J. M. Devoisselle, S. Begu, Dermal quercetin lipid nanocapsules: Influence of the formulation on antioxidant activity and cellular protection against hydrogen peroxide, International Journal Of Pharmaceutics 518 (2017) 167–176.
[8] M. K. Kemelo, A. Pierzynova, N. K. Canova, T. Kucera, H. Farghali, The involvement of sirtuin 1 and heme oxygenase 1 in the hepatoprotective effects of quercetin against carbon tetrachloride-induced sub-chronic liver toxicity in rats, Chemico-Biological Interactions 269 (2017) 1–8.
[9] A. Ghosh, A. K. Mandal, S. Sarkar, N. Das, Hepatoprotective and neuroprotective activity of liposomal quercetin in combating chronic arsenic induced oxidative damage in liver and brain of rats, Drug Delivery 18 (2011) 451–459.
[10] L. L. Ji, Y. C. Sheng, Z. Y. Zheng, L. Shi, Z. T. Wang, The involvement of p62-Keap1-Nrf2 antioxidative signaling pathway and JNK in the protection of natural flavonoid quercetin against hepatotoxicity, Free Radical Biology And Medicine 85 (2015) 12–23.
[11] I. M. Afifi NA, Galal M, Hepato-protective influence of quercetin and ellagic acid on thioacetamide-induced hepatotoxicity in rats, Can J Physiol Pharmacol 10.1139/cjpp–2017–0651 (2018).
[12] H. Zhuo, B. Zheng, J. Liu, Y. Huang, H. Wang, D. Zheng, N. Mao, J. Meng, S. Zhou, L. Zhong, Y. Zhao, Efficient targeted tumor imaging and secreted endostatin gene delivery by anti-CD105 immunoliposomes, J Exp Clin Cancer Res 37 (2018) 42.
[13] G. Wang, J. J. Wang, G. Y. Yang, S. M. Du, N. Zeng, D. S. Li, R. M. Li, J. Y. Chen, J. B. Feng, S. H. Yuan, F. Ye, Effects of quercetin nanoliposomes on C6 glioma cells through induction of type III programmed cell death, International Journal Of Nanomedicine 7 (2012) 271–280.
[14] P. Mukhopadhyay, S. Maity, S. Mandal, A. S. Chakraborti, A. K. Prajapatia, P. P. Kundu, Preparation, characterization and in vivo evaluation of pH sensitive, safe quercetin-succinylated chitosan-alginate core-shell-corona nanoparticle for diabetes treatment, Carbohydrate Polymers 182 (2018) 42–51.
[15] Z. Y. Zhang YD, Pan YF, Wang JW, Liu XY, Zhao ZY, Zhang LH, Long B., Study on distribution of liposome nanoparticles loaded quercetin in rats, China medical engineering 15 (2007) 305–308.
[16] H. Y. Zhang, D. W. Han, Z. F. Zhao, M. S. Liu, Y. J. Wu, X. M. Chen, C. Ji, Multiple pathogenic factor-induced complications of cirrhosis in rats: A new model of hepatopulmonary syndrome with intestinal endotoxemia, World Journal Of Gastroenterology 13 (2007) 3500–3507.
[17] E. Billerbeck, R. Wolfisberg, U. Fahnoe, J. W. Xiao, C. Quirk, J. M. Luna, J. M. Cullen, A. S. Hartlage, L. Chiriboga, K. Ghoshal, W. I. Lipkin, J. Bukh, T. K. H. Scheel, A. Kapoor, C. M. Rice, Mouse models of acute and chronic hepacivirus infection, Science 357 (2017) 204-+.
[18] F. J. Cubero, M. E. Zoubek, W. Hu, J. Peng, G. Zhao, Y. A. Nevzorova, M. Al Masaoudi, L. P. Bechmann, M. V. Boekschoten, M. Muller, C. Preisinger, N. Gassler, A. E. Canbay, T. Luedde, R. J. Davis, C. Liedtke, C. Trautwein, Combined Activities of JNK1 and JNK2 in Hepatocytes Protect Against Toxic Liver Injury, Gastroenterology 150 (2016) 968–981.
[19] L. Wang, W. Zhang, C. H. Ge, R. H. Yin, Y. Xiao, Y. Q. Zhan, M. Yu, C. Y. Li, Z. Q. Ge, X. M. Yang, Toll-Like Receptor 5 Signaling Restrains T-Cell/Natural Killer T-Cell Activation and Protects Against Concanavalin A-Induced Hepatic Injury, Hepatology 65 (2017) 2059–2073.
[20] M. W. Wang X, Fang C, Tian S, Zhu X, Yang L, Huang Z, Li H, Dusp14 protects against hepatic ischemia-reperfusion injury via Tak1 suppression., J Hepatol S0168–8278(17)32275–4. (2017).
[21] T. Nakao, Y. Ono, H. Dai, R. Nakano, A. Perez-Gutierrez, G. Camirand, H. Huang, D. A. Geller, A. W. Thomson, DAP12/TREM2 Expression by Mouse and Human Liver DC: Functional Implications and Regulation of Liver Ischemia-Reperfusion Injury, Hepatology (2018).
[22] H. Qiao, Y. Zhou, X. Qin, J. Cheng, Y. He, Y. Jiang, NADPH Oxidase Signaling Pathway Mediates Mesenchymal Stem Cell-Induced Inhibition of Hepatic Stellate Cell Activation, Stem Cells Int 2018 (2018) 1239143.
[23] F. F. Jia, Z. R. Tan, H. L. McLeod, Y. Chen, D. S. Ou-Yang, H. H. Zhou, Effects of quercetin on pharmacokinetics of cefprozil in Chinese-Han male volunteers, Xenobiotica 46 (2016) 896–900.
[24] V. Tzankova, D. Aluani, M. Kondeva-Burdina, Y. Yordanov, F. Odzhakov, A. Apostolov, K. Yoncheva, Hepatoprotective and antioxidant activity of quercetin loaded chitosan/alginate particles in vitro and in vivo in a model of paracetamol-induced toxicity, Biomedicine & Pharmacotherapy 92 (2017) 569–579.
[25] F. Y. Chen, L. F. Cao, H. X. Wan, M. Y. Zhang, J. Y. Cai, L. J. Shen, J. H. Zhong, H. Zhong, Quercetin enhances adriamycin cytotoxicity through induction of apoptosis and regulation of mitogen-activated protein kinase/extracellular signal-regulated kinase/c-Jun N-terminal kinase signaling in multidrug-resistant leukemia K562 cells, Molecular Medicine Reports 11 (2015) 341–348.
[26] C. Daglioglu, Enhancing Tumor Cell Response to Multidrug Resistance with pH-Sensitive Quercetin and Doxorubicin Conjugated Multifunctional Nanoparticles, Colloids And Surfaces B-Biointerfaces 156 (2017) 175–185.
[27] X. Li, Q. W. Jin, Q. Y. Yao, B. L. Xu, L. X. Li, S. C. Zhang, C. T. Tu, The Flavonoid Quercetin Ameliorates Liver Inflammation and Fibrosis by Regulating Hepatic Macrophages Activation and Polarization in Mice, Frontiers In Pharmacology 9 (2018).
[28] L. W. Wu, Q. H. Zhang, W. H. Mo, J. Feng, S. N. Li, J. J. Li, T. Liu, S. Z. Xu, W. W. Wang, X. Y. Lu, Q. Yu, K. Chen, Y. J. Xia, J. Lu, L. Xu, Y. Q. Zhou, X. M. Fan, C. Y. Guo, Quercetin prevents hepatic fibrosis by inhibiting hepatic stellate cell activation and reducing autophagy via the TGF-beta 1/Smads and PI3K/Akt pathways, Scientific Reports 7 (2017).
[29] J. Varshosaz, A. Jafarian, G. Salehi, B. Zolfaghari, Comparing different sterol containing solid lipid nanoparticles for targeted delivery of quercetin in hepatocellular carcinoma, Journal Of Liposome Research 24 (2014) 191–203.
[30] O. Karimi-Khouzani, E. Heidarian, S. A. Amini, Anti-inflammatory and ameliorative effects of gallic acid on fluoxetine-induced oxidative stress and liver damage in rats, Pharmacological Reports 69 (2017) 830–835.